# EDGAR Filing Document

**Accession Number:** 0001494891
**File Stem:** 0001753926-26-000903
**Filing Date:** 2026-5
**Character Count:** 6186
**Document Hash:** 267e1d06fff234d50145a15742f4a25c
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001753926-26-000903.hdr.sgml**: 20260518

**ACCESSION NUMBER**: 0001753926-26-000903

**CONFORMED SUBMISSION TYPE**: SD

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20260518

**DATE AS OF CHANGE**: 20260515

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Sensus Healthcare, Inc.
- **CENTRAL INDEX KEY:** 0001494891
- **STANDARD INDUSTRIAL CLASSIFICATION:** SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 271647271
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SD
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-37714
- **FILM NUMBER:** 26990284

**BUSINESS ADDRESS:**
- **STREET 1:** 851 BROKEN SOUND PARKWAY NW
- **STREET 2:** SUITE 215
- **CITY:** BOCA RATON
- **STATE:** FL
- **ZIP:** 33487
- **BUSINESS PHONE:** 561-922-5808

**MAIL ADDRESS:**
- **STREET 1:** 851 BROKEN SOUND PARKWAY NW
- **STREET 2:** SUITE 215
- **CITY:** BOCA RATON
- **STATE:** FL
- **ZIP:** 33487

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Sensus Healthcare, LLC
- **DATE OF NAME CHANGE:** 20100622

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**WASHINGTON, DC 20549**

**____________________**

**FORM SD**

**SPECIALIZED DISCLOSURE REPORT**

<br>**SENSUS HEALTHCARE, INC.**<br> (Exact name of registrant as specified in its charter)

---

| | | |
|:---|:---|:---|
| Delaware | 001-37714 | 27-1647271 |
| (State of Incorporation) | (Commission File Number) | (IRS Employer Identification No.) |
| 851 Broken Sound Pkwy., NW # 215, Boca Raton, Florida | 851 Broken Sound Pkwy., NW # 215, Boca Raton, Florida | 33487 |
| (Address of principal executive offices) | (Address of principal executive offices) | (Zip Code) |

---

Michael Sardano

President, General Counsel, Chief Commercial Officer, and Corporate Secretary

(561) 922-5808

(Name and telephone number, including area code, of the person to contact in connection with this report)

Check the appropriate box to indicate the rule pursuant to which this form is being filed, and provide the period to which the information in this form applies:

☒ Rule 13p-1 under the Securities Exchange Act (17 CFR 230.13p-1) for the reporting period from January 1 to December 31, 2025.

☐ Rule 13q-1 under the Securities Exchange Act (17 CFR 240.13q-1) for the reporting period for the fiscal year ended ______.

**Item 1.01. Conflict Minerals Disclosure and Report**

**Conflict Minerals Disclosure**

Sensus Healthcare, Inc. (the "Company") is a global pioneer in the development and delivery of non-invasive treatments for skin cancer and keloids. Leveraging its cutting-edge superficial radiotherapy (SRT and IG-SRT) technology, the Company provides healthcare providers with a highly effective, patient-centric treatment platform. With a dedication to driving innovation in radiation oncology, the Company offers solutions that are safe, precise, and adaptable to a variety of clinical settings.

This Form SD disclosure is presented to comply with Rule 13p-1 under the Securities Exchange Act of 1934, as amended ("Rule13p-1"). Pursuant to Rule 13p-1, the Company undertook to determine whether the products it manufactured or contracted to manufacture during the year ended December 31, 2025 contained conflict minerals necessary to the functionality or production of such products. "Conflict minerals" are defined as columbite-tantalite (coltan), cassiterite, gold, wolframite, or their derivatives, which are limited to tantalum, tin, and tungsten (the "Subject Minerals").

We do not purchase any Subject Minerals directly from mines, smelters or refiners, nor do we have any direct relationship with any mines or smelters that process the Subject Minerals. We also do not have any contractual relationships with any of our indirect suppliers. We rely on the direct supplier and manufacturer of our products to provide information about the existence and origin of any Subject Minerals contained in our products. We evaluated our products and determined that they contain one or more of the Subject Minerals.

We undertook a good-faith reasonable country of origin inquiry ("RCOI") to determine whether any Subject Minerals in our products originated from the Democratic Republic of the Congo or adjoining countries (the "DRC Region") or from recycled or scrap sources. Our means of determining the country of origin of the Subject Minerals contained in our products was through inquiries we made with the direct supplier and manufacturer of our products.

Our direct supplier responded to our inquiry by representing that none of the products it supplies to the Company, to its knowledge, contain Subject Minerals originating from the DRC Region, and that only "conflict free" Subject Minerals are present in its products. Our manufacturer responded to our inquiry by representing that none of the products it manufactures for the Company, to its knowledge, contain Subject Minerals originating from the DRC Region, and that only "conflict free" Subject Minerals are present in its products. The response from each of our direct supplier and manufacturer stated that such respective representations were made based on a supply chain investigation where statements, declarations, and sourcing data concerning origin of materials from all key suppliers were collected.

Based on the results of our RCOI and our due diligence to date, we have no reason to believe that any of the Subject Minerals contained in our products originated in the DRC Region.

A copy of this report on Form SD is publicly available on our corporate website at www.sensushealthcare.com/SEC-filings.

**<br>SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the duly authorized undersigned.

---

| | |
|:---|:---|
| **SENSUS HEALTHCARE, INC.** | **SENSUS HEALTHCARE, INC.** |
| By: | /s/ Michael Sardano |
| Name: | Michael Sardano |
| Title: | President, General Counsel, Chief Commercial Officer, and Corporate Secretary |
| Date: | May 15, 2026 |

---